Rockland Technimed

Developer of resonance imaging bio-scale products designed for the early diagnosis and treatment of hypoxia or ischemia injury. The company operates as a theranostic imaging company, that offers diagnosis and treatment of hypoxic injury through its patented metabolic magnetic resonance imaging medium and also focuses on MRI imaging applications for tumor detection, tracking tumor angiogenesis, assessing tissue viability in cases of neurological and cardiovascular catastrophes and noninvasive real-time tissue stress monitoring to evaluate normal and abnormal oxygen consumption rates, enabling healthcare professionals to treat and take care of the affected patients in an effective manner.